PRDM5 is silenced in human cancers and has growth suppressive activitiesQINGDONG DENG; SHI HUANG.Oncogene (Basingstoke). 2004, Vol 23, Num 28, pp 4903-4910, issn 0950-9232, 8 p.Article

WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteinsLUDES-MEYERS, John H; KIL, Hyunsuk; BEDNAREK, Andrzej K et al.Oncogene (Basingstoke). 2004, Vol 23, Num 29, pp 5049-5055, issn 0950-9232, 7 p.Article

RASSF6 is a novel member of the RASSF family of tumor suppressorsALIEN, N. P. C; DONNINGER, H; VOS, M. D et al.Oncogene (Basingstoke). 2007, Vol 26, Num 42, pp 6203-6211, issn 0950-9232, 9 p.Article

Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cellsMANGOURA, D; SUN, Y; LI, C et al.Oncogene (Basingstoke). 2006, Vol 25, Num 5, pp 735-745, issn 0950-9232, 11 p.Article

Control of apoptosis by p53FRIDMAN, Jordan S; LOWE, Scott W.Oncogene (Basingstoke). 2003, Vol 22, Num 56, pp 9030-9040, issn 0950-9232, 11 p., NS8Article

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureESTELLER, Manel.Oncogene (Basingstoke). 2002, Vol 21, Num 35, pp 5427-5440, issn 0950-9232, 14 p.Article

ATM activity contributes to the tumor-suppressing functions of p14^ARFYANXIA LI; DONGCHENG WU; BIAO CHEN et al.Oncogene (Basingstoke). 2004, Vol 23, Num 44, pp 7355-7365, issn 0950-9232, 11 p.Article

UTRN on chromosome 6q24 is mutated in multiple tumorsLI, Y; HUANG, J; ZHAO, Y.-L et al.Oncogene (Basingstoke). 2007, Vol 26, Num 42, pp 6220-6228, issn 0950-9232, 9 p.Article

Evaluation of the 3p21.3 tumour-suppressor gene clusterHESSON, L. B; COOPER, W. N; LATIF, F et al.Oncogene (Basingstoke). 2007, Vol 26, Num 52, pp 7283-7301, issn 0950-9232, 19 p.Article

E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cellsPILTTI, K; KEROSUO, L; HAKANEN, J et al.Oncogene (Basingstoke). 2006, Vol 25, Num 35, pp 4880-4889, issn 0950-9232, 10 p.Article

Cellular senescence and tumor suppressor gene p16RAYESS, Hani; WANG, Marilene B; SRIVATSAN, Eri S et al.International journal of cancer (Print). 2012, Vol 130, Num 8, pp 1715-1725, issn 0020-7136, 11 p.Article

Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgeryYUNES, Michael J; NEUSCHATZ, Andrew C; BORNSTEIN, Linda E et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 3, pp 653-657, issn 0360-3016, 5 p.Article

Expression of p33^ING1 mRNA and chemosensitivity in brain tumor cellsTALLEN, G; RIABOWOL, K; WOLFF, J. E. A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1631-1635, issn 0250-7005, 5 p.Article

pRb2/p130 : a new candidate for retinoblastoma tumor formationDE FALCO, G; GIORDANO, A.Oncogene (Basingstoke). 2006, Vol 25, Num 38, pp 5333-5340, issn 0950-9232, 8 p.Article

Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factorsTOUSSAINT-SMITH, Esra; DONNER, David B; ROMAN, Ann et al.Oncogene (Basingstoke). 2004, Vol 23, Num 17, pp 2988-2995, issn 0950-9232, 8 p.Article

ATF-2 controls transcription of Maspin and GADD45α genes independently from p53 to suppress mammary tumorsMAEKAWA, T; SANO, Y; SHINAGAWA, T et al.Oncogene (Basingstoke). 2008, Vol 27, Num 8, pp 1045-1054, issn 0950-9232, 10 p.Article

Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinaseGERARD, Audrey; FAVRE, Cédric; GARCON, Fabien et al.Oncogene (Basingstoke). 2004, Vol 23, Num 8, pp 1594-1598, issn 0950-9232, 5 p.Article

Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nfl) heterozygous miceGUTMANN, D. H; WINKELER, E; KABBARAH, O et al.Oncogene (Basingstoke). 2003, Vol 22, Num 29, pp 4581-4585, issn 0950-9232, 5 p.Article

ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junctionHARA, Yasuo; ZUOYU ZHENG; EVANS, Susan C et al.Cancer letters. 2003, Vol 192, Num 1, pp 109-116, issn 0304-3835, 8 p.Article

An opposing view on WWOX protein function as a tumor suppressorWATANABE, Akira; HIPPO, Yoshitaka; TANIGUCHI, Hirokazu et al.Cancer research (Baltimore). 2003, Vol 63, Num 24, pp 8629-8633, issn 0008-5472, 5 p.Article

Bi-allelic inactivation of the MEN1 tumor suppressor gene in human grade II astrocytomaKARGES, Wolfram; KARGES, Beate; LUDWIG, Leopold et al.Cancer letters. 2003, Vol 196, Num 1, pp 23-27, issn 0304-3835, 5 p.Article

Cell cycle-dependent phosphorylation of Disabled-2 by cdc2JUNQI HE; JIANGUO XU; XU, Xiang-Xi et al.Oncogene (Basingstoke). 2003, Vol 22, Num 29, pp 4524-4530, issn 0950-9232, 7 p.Article

Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samplesWAKI, Takayoshi; TAMURA, Gen; SATO, Makoto et al.Oncogene (Basingstoke). 2003, Vol 22, Num 26, pp 4128-4133, issn 0950-9232, 6 p.Article

The p53-p66Shc Apoptotic Pathway is Dispensable for Tumor Suppression whereas the p66Shc-generated Oxidative Stress Initiates Tumorigenesis : Pharmacological and Molecular Targets in Cellular Redox Status MaintenanceBELTRAMI, Elena; VALTORTA, Silvia; MORESCO, Rosamaria et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 15, pp 2708-2714, issn 1381-6128, 7 p.Article

Tissue factor in cancer and angiogenesis : The molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathyRAK, Janusz; MILSOM, Chloe; MAY, Linda et al.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 1, pp 54-70, issn 0094-6176, 17 p.Article